American Oncology Network Appoints New Vice President
of Business Development

Fort Myers, Fla., Nov. 8, 2021 – American Oncology Network, LLC (AON), a high-growth medical oncology provider with a focus on supporting the long-term viability of oncology treatment in community-based settings, announced that John Misitis has joined as Vice President of Business Development. In his role, Misitis will oversee business development with a primary focus on driving new relationships with providers to join the AON network. In addition to developing and executing plans to grow new business, Misitis will be responsible for maintaining relationships with existing practices to achieve revenue and profitability targets.

Misitis brings over 25 years in sales and business development, along with extensive experience in the physician practice management arena. Most recently he held a leadership position at AmerisourceBergen Oncology Supply, where he was instrumental in significant revenue growth and led critical positioning and sales generation exceeding topline growth of 10% and increasing gross profit by 17% year over year on $7.8B in sales.

In addition to his 13 years tenure with Oncology Supply, he spent 12 years prior with Johnson & Johnson Ortho Biotech serving oncology physician practices in several key roles. Rapidly advancing as part of the leadership team for PROCRIT®, a prescription medicine used to treat anemia, Misitis was responsible for the development and execution of strategies and tactics for sales in community oncology centers plus the long-term care market throughout eight states within the Mid-Atlantic and Eastern regions.

Misitis graduated with a Bachelor of Science in Business Administration and Marketing from Clarion University of Pennsylvania.

“The healthcare landscape is ever-evolving,” said AON Chief Growth & Relationship Officer Shelly Glenn. “John’s experience has ideally positioned him to anticipate future business challenges and proactively develop and implement new growth and diversification initiatives.”

AON Chief Executive Officer Todd Schonherz added: “As we strive to improve care and lower cost, John’s appointment supports our efforts to create an organization that delivers value to our partners, patients and the community. His ability to embrace change and think innovatively will help drive the organization towards improved outcomes helping to make a difference for healthcare providers and patients alike.”

###

About American Oncology Network, LLC: (AONcology.com)
American Oncology Network, LLC (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology. Launched in 2018, the rapidly growing AON network represents 104 physicians and 78 nurse practitioners and physician assistants practicing across 16 states. The executive management team of AON brings more than three decades of oncology practice management experience, enabling physicians to focus on what matters most – providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care.

AON also provides a unique model of physician led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences will be at the very pinnacle of cancer care today.

For More Information, Contact:
American Oncology Network, LLC
Caroline Hewitt, Vice President of Marketing
Caroline.Hewitt@AONcology.com

American Oncology Network, LLC & Cancer & Blood Specialists of Arizona Welcome Amber Flaherty, MD

Phoenix, Ariz., Nov. 1, 2021 – Drs. Snehal Bhoola, Tania Cortas, Mazen Khattab, Shana Wingo and Harshita Paripati of Cancer & Blood Specialists of Arizona (CBSA) welcome Medical Oncologist/Hematologist Amber Flaherty, MD to the community oncology practice. CBSA, an American Oncology Network, LLC (AON) partner, has three locations in the Greater Phoenix Area including the Northwest, East Valley and Phoenix/Scottsdale.

Dr. Flaherty is seeing patients in Phoenix/Scottsdale at 11209 N. Tatum Blvd, Suite B200 in Phoenix. She is a Board-certified medical oncologist and hematologist who treats patients with all cancer types and blood disorders, and specializes in genitourinary cancers focused on the kidney, bladder and prostate.

Dr. Flaherty earned her medical degree from St. George’s University Grenada, West Indies. She completed her residency in internal medicine at the University of Texas Health Science Center in Houston followed by fellowship training in hematology and oncology at Moffitt Cancer Center in Tampa, Fla.

Dr. Tania Cortas of Cancer & Blood Specialists of Arizona said, “Dr. Flaherty will be an asset to our team as she brings with her a passion for cancer research and has participated in several studies as the principal investigator.”

“The CBSA team is growing to meet the needs of our patients in the Phoenix area,” said AON President & Chief Development Officer Brad Prechtl, MBA. “With the addition of Dr. Flaherty, CBSA will now include four medical oncologists and two gynecologic oncologists helping to provide personalized care conveniently located close to home.”

Through its partnership with AON, CBSA offers state-of-the-art technology and the latest advances in clinical research and therapies, home delivery of oral oncolytic medications, 24/7 pharmacy assistance and pathology and laboratory services.

AON Chief Executive Officer Todd Schonherz, added “Dr. Flaherty is known for her customized approach to treatment, she takes the time to get to know her patients and their families to develop a plan that is best suited for them with the focus on enhancing their quality of life.”

###

About Cancer & Blood Specialists of Arizona: (CancerBloodSpecialistsAZ.com)
Cancer & Blood Specialists of Arizona is a community-based Medical Oncology, Gynecologic Oncology and Hematology practice providing treatment for patients diagnosed with all types of cancer and blood disorders. We are experienced physicians, nurse practitioners, nurses and clinical support staff providing compassionate, patient-centered care in Phoenix, Arizona, and surrounding areas. Our physicians have deep roots in the Greater Phoenix Area and are proud of our 40-year collective history of delivering the highest quality cancer treatment that is based on cutting-edge research.

About American Oncology Network, LLC: (AONcology.com)
American Oncology Network, LLC (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology. Launched in 2018, the rapidly expanding AON network represents 104 physicians and 78 nurse practitioners and physician assistants practicing across 16 states. The executive management team of AON encompasses more than three decades of oncology practice management experience, enabling physicians to focus on what matters most – providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care.

AON also provides a unique model of physician led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences will be at the very pinnacle of cancer care today.

For More Information, Contact:
American Oncology Network, LLC
Caroline Hewitt, Vice President of  Marketing
Caroline.Hewitt@AONcology.com

American Oncology Network Expands Footprint in Arizona
with the Addition of Pinal Cancer & Surgery Center

Fort Myers, Fla., Nov. 1, 2021 – American Oncology Network, LLC (AON), a high-growth national network of independent community oncologists, is pleased to announce that Pinal Cancer & Surgery Center in Casa Grande, Ariz., formerly Alliance Cancer Care and Alliance Surgery Arizona, joined AON effective November 1, 2021. This community-based practice is now the second practice in Arizona to partner with AON.

Pinal Cancer & Surgery Center (PCSC) provides general and oncology surgery specializing in minimally invasive, minor and major surgical conditions, as well as radiation oncology and medical oncology/hematology treatments and services for patients diagnosed with cancer and blood disorders. Making care easily accessible for patients, the cancer clinic and the surgery center are both conveniently located in Casa Grande.

PCSC treats a wide variety of tumor types while offering personalized care customized for each patient. Additionally, patients will have access to centralized laboratory and pathology, home delivery of oral cancer medications and care management support.

“We welcome Drs. Carlos Arce-Lara and Ramon Mourelo to our growing network of community oncology practices,” said AON President & Chief Development Officer Brad Prechtl, MBA. “The physicians and staff at Pinal Cancer & Surgery Center have an excellent reputation in the community and are truly dedicated to providing patients with comprehensive, integrated care.”

AON Chief Executive Officer Todd Schonherz added, “We have an expanding presence in Arizona. With the addition of this practice, we now have two additional community oncology clinics offering cancer patients care, close to home.”

“We are excited to partner with AON to provide innovative cancer care while offering our patients enhanced services that will improve their overall health during their cancer journey,” said PCSC Medical Oncologist & Hematologist Carlos Arce-Lara, MD.

AON was founded by well-respected leaders in community oncology with decades of experience helping oncology practices to thrive by providing proven solutions and ensuring that everyone has access to exceptional cancer care.

###

About Pinal Cancer & Surgery Center: (PinalCancerSurgery.com)
Pinal Cancer & Surgery Center (PCSC) specializes in the diagnosis and treatment of blood disorders and cancer. Our goal is to renew your hope in the future by providing professional and compassionate medical care close to home. The main clinic location and surgery center are in Casa Grande, Ariz. PCSC has a highly skilled team that works together at every stage of the diagnosis offering personalized cancer treatment to help make the best decisions in the fight against cancer

About American Oncology Network, LLC: (AONcology.com)
American Oncology Network, LLC (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology. Launched in 2018, the rapidly expanding AON network represents 104 physicians and 78 nurse practitioners and physician assistants practicing across 16 states. The executive management team of AON encompasses more than three decades of oncology practice management experience, enabling physicians to focus on what matters most – providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care.

AON also provides a unique model of physician led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences will be at the very pinnacle of cancer care today.

For More Information, Contact:
American Oncology Network, LLC
Caroline Hewitt, Vice President of  Marketing
Caroline.Hewitt@AONcology.com

American Oncology Network In-House Specialty Pharmacy Earns Third Accreditation

Fort Myers, Fla., Oct. 25, 2021 – The American Oncology Network, LLC (AON) in-house specialty pharmacy is pleased to announce their recent accreditations by the National Association of Boards of Pharmacy® (NABP®) for specialty pharmacy practice and for digital pharmacy practice. Already accredited with ACHC (Accreditation Commission for Health Care) and URAC (Utilization Review Accreditation Commission), the addition of the NABP accreditation makes three pharmacy accreditations in total, well above industry standards.

AON Sr. Pharmacy Director Douglas Braun, CSP, PharmD, RPh said, “Specialty pharmacies are in the care management business and the evolving role of specialty pharmacies in serving patients with complex, chronic diseases is critical to improving patient outcomes.”

NABP’s Specialty Pharmacy Accreditation signifies to patients, payers, and providers that the pharmacy organization is recognized for providing an advanced level of pharmacy services and disease management for patients taking medications that require special handling, storage and distribution requirements. Specialty pharmacies coordinate patient education, promote adherence and ensure appropriate medication use.

NABP’s Digital Pharmacy Accreditation signifies the pharmacy organization is recognized for its commitment to quality health care and safe pharmacy practices over the internet. The thorough review process included an on-site survey and the website was verified to review the pharmacy’s online presence and medication-related websites to ensure that they are properly licensed and follow applicable laws and business best practices.

This voluntary accreditation process demonstrates compliance to a comprehensive set of practice standards and evaluated the pharmacy on practice management, patient care services, and quality improvement. “NABP congratulates the AON Pharmacy on achieving this important recognition,” says NABP Executive Director/Secretary Lemrey “Al” Carter, PharmD, MS, RPh. “By earning Specialty Pharmacy Accreditation, they demonstrate their commitment to quality health care and patient safety, that improve overall health outcomes.”

“Specialty pharmacies that achieve accreditation demonstrate the highest value in delivering enhanced clinical services,” added AON Chief Executive Officer Todd Schonherz. “Many will attempt for dual accreditation but very few achieve triple accreditation, so we are very proud of this accomplishment.”

AON Chief Pharmacy & Procurement Officer James Gilmore stated, “Obtaining accreditation from three different governing bodies demonstrates AON’s commitment to excellence and our ability to provide superior care to our patients.”

###

About the National Association of Boards of Pharmacy (NABP.pharmacy.com)
The National Association of Boards of Pharmacy (NABP) is the impartial professional organization that supports its member regulatory state boards of pharmacy in creating uniform regulations to protect public health. Founded in 1904, NABP aims to ensure the public’s health and safety through its pharmacist competence assessment programs, license transfer and verification services, as well as through pharmacy inspection and accreditation programs. For more information, please visit www.nabp.pharmacy.

About American Oncology Network, LLC: (AONcology.com)
American Oncology Network, LLC (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology. Launched in 2018, the rapidly growing AON network represents 102 physicians and 75 nurse practitioners and physician assistants practicing across 17 states. The executive management team of AON brings more than three decades of oncology practice management experience, enabling physicians to focus on what matters most – providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care.

AON also provides a unique model of physician led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences will be at the very pinnacle of cancer care today.

For More Information, Contact:
American Oncology Network, LLC
Caroline Hewitt, Vice President of Marketing
Caroline.Hewitt@AONcology.com

American Oncology Network & Sarah Cannon Research Institute Expand Cancer Research Collaboration with Addition of Genesis Cancer and Blood Institute

Fort Myers, Fla. & Nashville, Tenn., Sept. 22, 2021 — American Oncology Network, LLC (AON) and Sarah Cannon Research Institute announced today the addition of AON partner practice Genesis Cancer and Blood Institute (Genesis), as a strategic research site. Hematology/Oncology Clinic in Baton Rouge, La., Messino Cancer Centers in Asheville, N.C., and Zangmeister Cancer Center in Columbus, Ohio, all partner practices of AON, are also strategic research sites under this partnership, which brings greater access to cutting-edge therapies through clinical trials for patients.

For close to 30 years, Genesis has been participating in clinical trials. This new partnership with Sarah Cannon Research Institute will provide patients access to an expanded menu of clinical trials and advanced therapies. Genesis Medical Oncologists serving patients in Hot Springs are Dr. Timothy Webb, Dr. Robert T. Muldoon, Dr. Stephen “Fred” Divers, Dr. Lynn Cleveland and Dr. Lingyi Chen.

“The physicians at Genesis Cancer and Blood Institute are committed to delivering advanced treatment options for the best possible outcomes for their patients,” said AON CEO Todd Schonherz. “By partnering with Sarah Cannon Research Institute, we are combining our exceptional local physician expertise with internationally-recognized teams and research to improve care and match patients with potentially life-saving treatments while staying within the comfort and familiarity of their oncologist’s office.”

AON Vice President of Clinical Research Katie Goodman added, “In the world of oncology, clinical research is a major force in the advancement of treatments for different cancers. Clinical trials also help us improve the quality of life for patients during and after treatment.”

AON is currently comprised of an expanding network of partner practices across 17 states. AON practices offer in-house laboratory, pathology and oral pharmacy services all under one roof so that patients can receive the care they need in one location. Research has shown that having easy and convenient access to expert physician care and a comprehensive range of treatments and support services close to home is vital to a patient’s well-being. By collaborating with Sarah Cannon Research Institute, which is a global leader in offering community-based clinical trials, AON is providing opportunities for patients to participate in cutting-edge cancer research, while reducing the need to drive long distances or travel out of state for care.

Sarah Cannon Research Institute pioneered the first community-based oncology drug development program in the United States and has grown to become a global leader in early phase research, conducting more than 500 first-in-human studies to date. Through its efforts to advance therapies for patients, Sarah Cannon Research Institute has been a clinical trial leader in the majority of approved cancer therapies over the last decade.

“Through our partnership with AON, we are furthering our mission to bring cutting-edge therapies into the community so patients can stay close to home while accessing the treatment options they need,” said Howard A. “Skip” Burris, III, MD, President of Clinical Operations and Chief Medical Officer at Sarah Cannon. “We look forward to working together with the experts at Genesis Cancer and Blood Institute to offer clinical trials for people facing cancer in Hot Springs.”

###

About American Oncology Network, LLC: (AONcology.com)
American Oncology Network, LLC (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology. Launched in 2018, the rapidly expanding AON network currently represents 102 physicians and 75 nurse practitioners and physician assistants practicing across 17 states. The executive management team of AON encompasses more than three decades of oncology practice management experience, enabling physicians to focus on what matters most – providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care.

AON also provides a unique model of physician-led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences will be at the very pinnacle of cancer care today.

About Sarah Cannon Research Institute: (SarahCannon.com)
Sarah Cannon Research Institute is the research arm of HCA Healthcare’s Cancer Institute, Sarah Cannon. Focused on advancing therapies for patients, it is one of the world’s leading clinical research organizations conducting community-based clinical trials throughout the United States and United Kingdom. A leader in drug development, Sarah Cannon has led more than 500 first-in-human clinical trials since its inception in 1993, and has been a clinical trial leader in the majority of approved cancer therapies over the last 10 years. Additionally, Sarah Cannon offers management, regulatory, and other research support services for drug development and industry sponsors as well as strategic investigator sites through its contract research organization (CRO), Sarah Cannon Development Innovations.

For More Information, Contact:
Caroline Hewitt
Vice President of Marketing, American Oncology Network, LLC 
Caroline.Hewitt@AONcology.com

Sarah Cannon Research Institute
Samantha Maxwell
Samantha.Maxwell@sarahcannon.com

Genesis Cancer and Blood Institute Expands to the Russellville Area

Russellville, Ark., Sept. 20, 2021 Genesis Cancer and Blood Institute (Genesis) is pleased to announce the opening of their new cancer center location in Russellville, Ark. at 1808 West Main Street, Russellville, Ste 200. This new clinic is the 10th Genesis location, continuing to focus on making it easier for patients to have access to the highest quality cancer care close to where they live.

For 30 years, Genesis has provided oncology and hematology care to thousands of patients throughout southern Arkansas with the mission of “making cancer a memory.”

“Knowing that care close to home is truly important to our patients, we continue to evaluate our clinic locations and decided to open this new Russellville location,” said Genesis Cancer and Blood Institute Medical Oncologist and founder Dr. Timothy Webb.

The physicians at Genesis place a strong emphasis on offering the latest treatment options, clinical trials and patient education. Genesis has additional expanded services in the main Hot Springs location, offering patients access to diagnostic PET/CT imaging and onsite review. Genesis offers patients a fully integrated treatment plan, including pathology, labs and radiology, making it easier to accelerate treatment.

Genesis joined the American Oncology Network (AON) in 2018 to help provide the best cancer care with additional services including efficient home delivery of oral cancer medications, care management, access to clinical trials and financial assistance. This partnership with AON is a multi-state alliance of physicians and veteran healthcare leaders supporting the long-term viability of community oncology.

AON CEO Todd Schonherz said, “Genesis and AON believe every patient deserves access to top quality cancer care and clinical trials in the communities where they live and work and have their support system close by.”

“We opened the Russellville location based on our mission of bringing the latest cancer treatments with affordable care that is conveniently located where our patients live,” added AON President & Chief Development Officer Brad Prechtl, MBA.

###

About Genesis Cancer and Blood Institute: (GenesisCancerBlood.com)
Specializing in the diagnosis and treatment of cancer and hematology, Genesis Cancer and Blood Institute is recognized for providing expert cancer care in Arkansas. The highly trained physicians, clinicians and staff are committed to ensuring the best possible outcomes for their patients. The medical oncology/hematology physicians at Genesis Cancer and Blood Institute include Dr. R. Timothy Webb, Dr. Robert T. Muldoon, Dr. Stephen “Fred” Divers, Dr. A. Lynn Cleveland and Dr. Lingyi Chen.

About American Oncology Network, LLC: (AONcology.com)
American Oncology Network, LLC (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology. Launched in 2018, the rapidly expanding AON network represents 102 physicians and 75 nurse practitioners and physician assistants practicing across 17 states. The executive management team of AON encompasses more than three decades of oncology practice management experience, enabling physicians to focus on what matters most – providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care.

AON also provides a unique model of physician-led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences will be at the very pinnacle of cancer care today.

For More Information, Contact:
American Oncology Network, LLC
Caroline Hewitt, Vice President of  Marketing
Caroline.Hewitt@AONcology.com

Genesis Cancer Center Announces Rebranding, Changes Name to
Genesis Cancer and Blood Institute

Fort Myers, Fla. & Hot Springs, Ark., Sept. 16, 2021 Genesis Cancer Center (Genesis), serving Hot Springs and surrounding communities in oncology/hematology, recently unveiled new branding in response to patient needs. For over 30 years, Genesis has provided the highest quality cancer care customized for the needs of each individual patient and will continue to deliver that same level of care and personalization in ten locations throughout southern and central Arkansas.

At the heart of this rebranding is a change of the practice name to Genesis Cancer and Blood Institute. The Genesis name is rooted in the practice’s commitment to hope, compassionate patient care and comprehensive state-of-the-art treatment.

“We believe the new name is a better reflection of what we offer to our patients, referring providers and the communities we serve,” said Genesis Cancer and Blood Institute Medical Oncologist and founder Dr. Timothy Webb. He added, “We go beyond the cancer diagnosis, consulting for benign and malignant hematology, including blood banking, clotting abnormalities, immunology and infusion services for the newer targeted and immunological treatments available in GI, Dermatology and Rheumatology issues.”

Genesis also offers many conveniences for the patient, providing radiology scans on campus, participation in the largest access to clinical trials and investigational studies through a partnership with Sarah Cannon Research Institute and the benefits of Our Promise Cancer Resource, a nonprofit that Genesis created over 10 years ago, donating $1.2 million dollars to help ease the burden of patient expenses while they undergo treatment.

AON CEO Todd Schonherz added, “Although the Genesis rebrand brings a new identity, the level of care will not change. Genesis remains committed to bringing expert cancer care and treatments close to where patients and their support systems live.”

Genesis is part of the American Oncology Network (AON)—a leading physician network helping community oncologists have greater access to more resources so patients get top-level cancer care within their communities.

###

About Genesis Cancer and Blood Institute: (GenesisCancerBlood.com)
Specializing in the diagnosis and treatment of cancer and hematology, Genesis Cancer and Blood Institute is recognized for providing expert cancer care in Arkansas. The highly trained physicians, clinicians and staff are committed to ensuring the best possible outcomes for their patients. The medical oncology/hematology physicians at Genesis Cancer and Blood Institute include Dr. R. Timothy Webb, Dr. Robert T. Muldoon, Dr. Stephen “Fred” Divers, Dr. A. Lynn Cleveland and Dr. Lingyi Chen. 

About American Oncology Network, LLC: (AONcology.com)
American Oncology Network, LLC (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology. Launched in 2018, the rapidly expanding AON network represents 102 physicians and 75 nurse practitioners and physician assistants practicing across 17 states. The executive management team of AON encompasses more than three decades of oncology practice management experience, enabling physicians to focus on what matters most – providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care.

AON also provides a unique model of physician-led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences will be at the very pinnacle of cancer care today.

For More Information, Contact:
American Oncology Network, LLC
Caroline Hewitt, Vice President of  Marketing
Caroline.Hewitt@AONcology.com

American Oncology Network, LLC & Summit Cancer Centers Welcome Max Seaton, MD

Fort Myers, Fla., September 15, 2021 – The team of eight medical, surgical, and radiation oncologists from Summit Cancer Centers (Summit) welcome Dr. Max Seaton to the community oncology practice.  Summit, an American Oncology Network, LLC (AON) partner, has eight locations, serving patients in eastern Washington and Idaho.

Dr. Seaton is seeing patients in the Spokane and Spokane Valley locations.  He is Board certified in Surgery and Board eligible in Surgical Oncology.  He earned his medical degree from Boston University School of Medicine, and then went on to complete his general surgery residency at the University of Maryland Medical Center in Baltimore, Maryland.

“We are thrilled to welcome Dr. Seaton to our practice.  He works very closely with the medical and radiation oncology team to develop a personalized treatment plan for his patients, fitting in perfectly with our practice approach of individualized patient care and treatment,” said Summit Medical Oncologist Arvind Chaudhry, MD, PhD.

The Summit team includes Medical Oncologists Arvind Chaudhry, MD, PhD, Bruce Cutter, MD, Carolyn Aks, MD, Stephanie Hodson, MD, Mirela Andrei, MD; Surgical Oncologists Aaron Saunders, MD, MAS, DABS, Max Seaton, MD; and Radiation Oncologists Karie-Lynn Kelly, MD and Jonathan Sharrett, DO.

AON President & Chief Development Officer Brad Prechtl, MBA stated, “His training is impressive, during his residency he also completed a two-year research fellowship at the National Institutes of Health. We know Dr. Seaton will be an asset to our team.”

“We are fortunate to have a surgical oncologist with expertise in a wide variety of cancer treatments including esophageal, stomach, liver, pancreas, bile ducts, small bowel, colon, breast, skin, soft tissue and the peritoneal surface,” added AON CEO Todd Schonherz.

With the addition of Dr. Seaton, the Summit team now includes two surgical oncologists, helping to ensure that their patients have access to exceptional cancer care and treatment close to where they live.

Summit Cancer Centers is a leading cancer center offering comprehensive cancer services from diagnostic imaging, cancer treatments with the most advanced therapies and technologies, clinical trials to onsite oral chemotherapy and lab services. Cancer treatments include surgical oncology, chemotherapy, immunotherapy, and other medical oncology therapies.

###

About American Oncology Network, LLC

American Oncology Network, LLC (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology. Launched in 2018, the rapidly expanding AON network represents 102 physicians and 75 nurse practitioners and physician assistants practicing across 17 states. The executive management team of AON encompasses more than three decades of oncology practice management experience, enabling physicians to focus on what matters most – providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care.

AON also provides a unique model of physician led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences will be at the very pinnacle of cancer care today.

About Summit Cancer Centers

Summit Cancer Centers is a community-based medical and surgical oncology practice providing care for patients diagnosed with all types of cancer and blood disorders. We are experienced physicians, nurse practitioners, nurses and clinical support staff providing compassionate, patient-centered care in Washington, Idaho, Montana, Oregon and western Canada.

Services include diagnostic testing, pathology and lab services, specialty pharmacy and a complimentary wellness program with acupuncture, cancer massage and nutritional counseling.

For More Information, Contact:
American Oncology Network, LLC
Caroline Hewitt
Vice President of Marketing
Caroline.Hewitt@AONcology.com

American Oncology Network Partners with Precipio to Bring HemeScreen® into AON’s Laboratory

HemeScreen Assays will enable AON to deliver rapid patient diagnostics for hematologic malignancies through advanced molecular screening technology

New Haven, CT, and Fort Myers, FL, August 26, 2021 – Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), and American Oncology Network, LLC (AON), a high-growth community oncology provider, announces the signing of an agreement under which AON will adopt Precipio’s HemeScreen® technology and begin running HemeScreen in its central laboratory located in Fort Myers, Florida.

AON will be the largest Physician Owned Laboratory (POL) to bring HemeScreen into their laboratory thus far. With over 100 physicians, and serving close to 100,000 unique patients annually, the impact to patient care will be substantial. Running HemeScreen in-house will enable AON to shorten diagnostic turnaround time of these tests (currently being sent out) from 2-4 weeks, to as fast as 1-4 days when run in house. For patients awaiting their diagnosis to begin treatment, and for the physicians awaiting the results to determine the right treatment, this capability will have an incredibly meaningful impact.

“The AON laboratory is a state-of-the-art facility supporting our physicians across 17 states with specialized expertise in oncology and hematology that helps to inform and direct the very best care plan and clinical outcome for each patient,” states AON CEO Todd Schonherz. “Being able to leverage Precipio’s HemeScreen technology will allow for turnaround times superior to industry norms enabling quicker diagnosis, earlier patient treatment and reducing patient anxiety.”

“Having a group such as AON adopt HemeScreen is a demonstration of how the most innovative physician practices utilize technology opportunities developed by biotech companies such as Precipio,” said Ilan Danieli, CEO of Precipio. “We are excited about the opportunity to work with a group of AON’s magnitude to impact patient care in the most meaningful way possible, touching patients at the heart of the community.”

This multi-year agreement will provide Precipio with seven-figure revenue per year. As Precipio continues to develop additional panels, AON will have an opportunity to further broaden the suite of assays run utilizing the HemeScreen technology.

###

About American Oncology Network, LLC: (AONcology.com)
American Oncology Network, LLC (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology. Launched in 2018, the rapidly growing AON network represents 102 physicians and 71 nurse practitioners and physician assistants practicing across 17 states. The executive management team of AON brings more than three decades of oncology practice management experience, enabling physicians to focus on what matters most – providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care.

AON also provides a unique model of physician led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences will be at the very pinnacle of cancer care today.

About Precipio

Precipio has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide, as well as proprietary products that serve laboratories worldwide. Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment such as the Yale School of Medicine, Harvard’s Dana-Farber Cancer Institute, and the University of Pennsylvania, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care. For more information, please visit www.precipiodx.com. Please follow us on Twitter @PrecipioDx and on Facebook.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including, among others, statements related to the expected or potential impact of the novel coronavirus (COVID-19) pandemic, and the related responses of the government, consumers, and the company, on our business, financial condition and results of operations, and any such forward-looking statements, whether concerning the COVID-19 pandemic or otherwise, involve risks, assumptions and uncertainties. Except for historical information, statements about future volumes, sales, growth, costs, cost savings, margins, earnings, earnings per share, diluted earnings per share, cash flows, plans, objectives, expectations, growth or profitability are forward-looking statements based on management’s estimates, beliefs, assumptions and projections. Words such as “could,” “may,” “expects,” “anticipates,” “will,” “targets,” “goals,” “projects,” “intends,” “plans,” “believes,” “seeks,” “estimates,” “predicts,” and variations on such words, and similar expressions that reflect our current views with respect to future events and operational, economic and financial performance, are intended to identify such forward-looking statements. These forward-looking statements are only predictions, subject to risks and uncertainties, and actual results could differ materially from those discussed. Important factors that could affect performance and cause results to differ materially from management’s expectations, or could affect the company’s ability to achieve its strategic goals, include the uncertainties relating to the impact of COVID-19 on the company’s business, operations and employees and the other factors that are described in the sections entitled “Risk Factors” and “Management’s Discussion and Analysis” in the company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2020, as updated from time to time in the company’s Securities and Exchange Commission filings. The company’s forward-looking statements in this press release are based on management’s current views, beliefs, assumptions and expectations regarding future events and speak only as of the date of this release. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by the federal securities laws.

Inquiries:

investors@precipiodx.com
+1-203-787-7888 Ext. 523
American Oncology Network, LLC
Caroline Hewitt, Vice President of Marketing
Caroline.Hewitt@AONcology.com

American Oncology Network, LLC & Messino Cancer Centers
Welcome Emily Miller, MD

Fort Myers, Fla., August 9, 2021 – The team of 15 medical oncologists from Messino Cancer Centers (MCC) welcome Dr. Emily Miller to the community oncology practice. MCC, an American Oncology Network, LLC (AON) partner, has six office locations in Western North Carolina, in Asheville, Brevard, Franklin, Spruce Pine, Marion and Sylva.

Dr. Miller is seeing patients in Asheville and Franklin. She is Board certified in internal medicine. As a medical oncologist/hematologist, she treats patients with all cancer types and blood disorders, and has a special interest in breast cancer care.

Dr. Miller earned her medical degree from the University of South Carolina School of Medicine Columbia followed by a residency in internal medicine from Palmetto Health Richland. She completed her fellowship training in medical oncology and hematology at the University of Tennessee West Cancer Center in Memphis.

Dr. Michael Messino founder of Messino Cancer Centers said, “Dr. Miller’s passion for fostering relationships with her patients and their families while guiding them through the entire cancer journey is why she is a perfect fit for our team and we are excited to have her!”

For over 30 years, MCC has been providing high quality cancer care in the Western North Carolina region, conveniently located close to where patients live.

“We welcome Dr. Miller to our team. She prides herself on being an advocate for her patients and truly embodies the community oncology care model of delivering compassionate care with individualized treatments based on each patient,” said AON President & Chief Development Officer Brad Prechtl, MBA.

AON CEO Todd Schonherz added, “Dr. Miller wanted to join us in community oncology because of her strong beliefs in that every patient deserves access to top quality cancer care and clinical trials. This philosophy is the foundation of Messino and AON.”

Through its partnership with AON, the practice offers home delivery of oral oncolytic medications, 24/7 pharmacy assistance, pathology and laboratory services, care management support and palliative care, and access to clinical trials.

###

About Messino Cancer Centers: (MessinoCancerCenters.com)
Messino Cancer Centers (MCC) provides treatment for adult patients diagnosed with all types of cancer and blood disorders. We are experienced physicians, advanced practice providers, nurses and clinical support staff dedicated to providing the most advanced and innovative treatments of the highest quality. We work together as a team and recognize that each patient is not just a person with cancer, but a unique individual. Care is provided with the utmost concern and consideration of what is best for the whole person throughout their cancer journey.

MCC physicians provide state-of-the-art evidence-based medicine for patients, incorporating personalized medicine, standard and nationally accepted guidelines, and clinical trials. Through care management and dedicated oncology certified staff, we provide support for patients through all phases of their diagnosis and treatment. The physicians of MCC are grounded in the region of Western North Carolina and devoted to providing care to patients in their communities.

About American Oncology Network, LLC: (AONcology.com)
American Oncology Network, LLC (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology. Launched in 2018, the rapidly expanding AON network represents 102 physicians and 71 nurse practitioners and physician assistants practicing across 17 states. The executive management team of AON encompasses more than three decades of oncology practice management experience, enabling physicians to focus on what matters most – providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care.

AON also provides a unique model of physician led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences will be at the very pinnacle of cancer care today.

For More Information, Contact:
American Oncology Network, LLC
Caroline Hewitt
Vice President of  Marketing
Caroline.Hewitt@AONcology.com
(941) 224.8736